The Safety and Efficacy of Cilostazol in Ischemic Stroke Patients With Peripheral Arterial Disease (SPAD Study)
Status:
Completed
Trial end date:
2013-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to investigate the Safety and Efficacy of Cilostazol in slowing
down the progression of peripheral arterial disease (PAD) in ischemic stroke patients with
PAD in Taiwan.
Phase:
Phase 4
Details
Lead Sponsor:
China Medical University Hospital
Collaborators:
Cathay General Hospital Changhua Christian Hospital Chi Mei Medical Hospital Chung Shan Medical University E-DA Hospital En Chu Kong Hospital Far Eastern Memorial Hospital Kaohsiung Medical University Chung-Ho Memorial Hospital Kuang Tien General Hospital Mackay Memorial Hospital National Cheng-Kung University Hospital National Taiwan University Hospital Shin Kong Wu Ho-Su Memorial Hospital Taipei Veterans General Hospital, Taiwan Tri-Service General Hospital